RxDoctor Payments Data

Sami Moufawad, MD

Pain Medicine · Richmond Hts, OHNPI 1558490748

Payments from drug & device makers

$5,596in general payments, 2019–2025

Across 277 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$2K
  • Abbott$1K
  • Arbor Pharmaceuticals, Inc.$726
  • Biodelivery Sciences International, Inc.$317
  • Boston Scientific$288
  • Azurity Pharmaceuticals, Inc.$251
  • plus $952 from 15 others

What the payments were for

  • Food & beverage$5,52699%
  • Education$711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,596 in reported general payments places this provider in the 70th percentile of 245 pain medicine providers in Ohio.

See all pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$97,982
Medicare patients
174
Services billed
1,015

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl75$54,978
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,867$48,855
Xtampza ErOxycodone Myristate45$38,652
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen789$18,006
Oxymorphone Hcl ErOxymorphone Hcl12$13,755
LyricaPregabalin15$11,129
Oxycodone Hcl537$10,921
Gabapentin728$8,040
MovantikNaloxegol Oxalate19$7,924
Morphine Sulfate ErMorphine Sulfate272$7,760
Pregabalin251$5,977
Diclofenac Epolamine13$5,656
Lidocaine54$4,118
Cyclobenzaprine Hcl368$3,617
Hysingla ErHydrocodone Bitartrate11$3,463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$1,820$38,65245 claims
PfizerLyrica$59$11,12915 claims
Redhill Biopharma Inc.Movantik$105$7,92419 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$219$3,40737 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 245 pain medicine providers in Ohio.

Other pain medicine in Richmond Hts

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →